OPTIMIZERx Corp (OPRX)

Currency in USD
17.30
+4.46(+34.74%)
Closed·
After Hours
17.45+0.15(+0.87%)
·
OPRX Scorecard
Full Analysis
Net income is expected to grow this year
Unusual trading volume
Trading near 52-week High
OPRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.3118.22
52 wk Range
3.7818.22
Key Statistics
Prev. Close
12.84
Open
16.25
Day's Range
14.31-18.22
52 wk Range
3.78-18.22
Volume
2.34M
Average Volume (3m)
329.22K
1-Year Change
106.44%
Book Value / Share
6.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.17
Downside
-6.55%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings downwards for the upcoming period

OPTIMIZERx Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

OPTIMIZERx Corp Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

Employees
129

OPTIMIZERx Corp SWOT Analysis


Digital Health Pionee
OptimizeRx leads in digital health messaging, leveraging AI and strategic acquisitions to revolutionize pharmaceutical marketing in a rapidly evolving healthcare landscape.
Financial Crossroads
Despite recent revenue challenges, OptimizeRx maintains strong growth metrics and healthy margins, with analysts projecting price targets ranging from $6 to $16.
DAAP: Growth Engine
Explore the potential of OptimizeRx's Digital Advertising Awareness Platform, offering higher margins and larger deal sizes, with significant upsell opportunities among existing clients.
Navigating Headwinds
Delve into OptimizeRx's strategies for overcoming contract delays, policy uncertainties, and competitive pressures while capitalizing on the shift to digital pharma marketing.
Read full SWOT analysis

OPTIMIZERx Corp Earnings Call Summary for Q2/2025

  • OptimizeRx Q2 2025 EPS of $0.24 beat $0.02 forecast; revenue of $29.2M up 55% YoY, exceeding estimates by 31.18%
  • Net income turned positive at $1.5M, reversing $4M loss YoY; stock surged 23.05% in premarket trading
  • Full-year revenue guidance raised to $104M-$108M; adjusted EBITDA projected at $14.5M-$17.5M
  • CEO confident in meeting 2026 consensus projections; CFO sees potential for $150M top line with current headcount
  • Subscription contracts growing, now 5-10% of revenue; analysts revise earnings estimates upward for upcoming period
Last Updated: 08/08/2025, 10:50
Read Full Transcript

Compare OPRX to Peers and Sector

Metrics to compare
OPRX
Peers
Sector
Relationship
P/E Ratio
−32.5x−1.1x−0.5x
PEG Ratio
−0.690.020.00
Price/Book
2.7x1.2x2.6x
Price / LTM Sales
3.1x1.5x3.3x
Upside (Analyst Target)
−7.5%30.5%43.4%
Fair Value Upside
Unlock42.2%7.1%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.17
(-6.55% Downside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.24 / 0.02
Revenue / Forecast
29.20M / 22.26M
EPS Revisions
Last 90 days

OPRX Income Statement

People Also Watch

247.45
AVAV
-4.68%
159.03
CRCL
+3.99%
120.41
CRDO
+0.53%
25.80
OUST
+11.69%
179.28
ALAB
+4.91%

FAQ

What Stock Exchange Does OPTIMIZERx Trade On?

OPTIMIZERx is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for OPTIMIZERx?

The stock symbol for OPTIMIZERx is "OPRX."

What Is the OPTIMIZERx Market Cap?

As of today, OPTIMIZERx market cap is 321.02M.

What Is OPTIMIZERx's Earnings Per Share (TTM)?

The OPTIMIZERx EPS (TTM) is -0.54.

When Is the Next OPTIMIZERx Earnings Date?

OPTIMIZERx will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is OPRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has OPTIMIZERx Stock Split?

OPTIMIZERx has split 3 times.

How Many Employees Does OPTIMIZERx Have?

OPTIMIZERx has 129 employees.

What is the current trading status of OPTIMIZERx (OPRX)?

As of 10 Aug 2025, OPTIMIZERx (OPRX) is trading at a price of 17.30, with a previous close of 12.84. The stock has fluctuated within a day range of 14.31 to 18.22, while its 52-week range spans from 3.78 to 18.22.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.